Brief: Lyra Therapeutics Announces $15M Direct Offering and Private Placement Priced At-Market Under Nasdaq Rules
27/06/2025 13:05
June 27 (Reuters) - Lyra Therapeutics Inc LYRA.O: LYRA THERAPEUTICS ANNOUNCES UP TO APPROXIMATELY $15 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES LYRA THERAPEUTICS INC - COMBINED EFFECTIVE PURCHASE PRICE PER SHARE IS $11.81 Source text: ID:nGNXc56cVb Further company coverage: LYRA.O ((Reuters.Briefs@thomsonreuters.com;))